Crow Point Partners Lowered By $444,503 Its Lockheed Martin (LMT) Stake; Eventide Asset Management Has Upped By $1.24 Million Its Exact Sciences (EXAS) Holding

June 17, 2018 - By Hazel Jackson

Lockheed Martin Corporation (NYSE:LMT) Logo

Eventide Asset Management Llc increased Exact Sciences Corp (EXAS) stake by 31% reported in 2018Q1 SEC filing. Eventide Asset Management Llc acquired 31,000 shares as Exact Sciences Corp (EXAS)’s stock rose 21.76%. The Eventide Asset Management Llc holds 131,000 shares with $5.28M value, up from 100,000 last quarter. Exact Sciences Corp now has $8.35 billion valuation. The stock increased 1.53% or $1.03 during the last trading session, reaching $68.53. About 1.05 million shares traded. Exact Sciences Corporation (NASDAQ:EXAS) has risen 56.13% since June 17, 2017 and is uptrending. It has outperformed by 43.56% the S&P500. Some Historical EXAS News: ; 01/05/2018 – Exact Sciences Presenting at Bank of America Conference May 15; 26/04/2018 – EXACT Sciences 1Q Rev $90.3M; 14/05/2018 – Exact Sciences at Bank of America Conference Tomorrow; 23/04/2018 – DJ Exact Sciences Corporation, Inst Holders, 1Q 2018 (EXAS); 01/05/2018 – Exact Sciences to participate in two investor conferences during May; 06/03/2018 – Detailed Research: Economic Perspectives on Exact Sciences, KapStone Paper and Packaging, Spirit Realty Capital, KLA-Tencor, Ne; 26/04/2018 – Exact Sciences Closes Above 50-Day Moving Average: Technicals; 02/05/2018 – Exact Sciences: A Big Opportunity? — Barrons.com; 26/04/2018 – EXACT Sciences Sees 2018 Rev $420M-$430M; 26/04/2018 – EXACT SCIENCES CORP EXAS.O SEES FY 2018 REVENUE $420 MLN TO $430 MLN

Crow Point Partners Llc decreased Lockheed Martin Corp (LMT) stake by 44.46% reported in 2018Q1 SEC filing. Crow Point Partners Llc sold 1,319 shares as Lockheed Martin Corp (LMT)’s stock declined 10.57%. The Crow Point Partners Llc holds 1,648 shares with $557,000 value, down from 2,967 last quarter. Lockheed Martin Corp now has $88.55B valuation. The stock decreased 0.14% or $0.45 during the last trading session, reaching $310.14. About 1.79 million shares traded or 20.51% up from the average. Lockheed Martin Corporation (NYSE:LMT) has risen 13.73% since June 17, 2017 and is uptrending. It has outperformed by 1.16% the S&P500. Some Historical LMT News: ; 05/03/2018 – Lockheed Martin CEO: Foreign defense customers unlikely to retaliate against us due to Trump tariffs; 26/04/2018 – Three U.S. senators move to block F-35 transfers to Turkey; 09/05/2018 – ActiveState Offers Way to Ship Software Faster & Keep Control; 04/05/2018 – U.S. STATE DEPARTMENT HAS APPROVED POSSIBLE MILITARY AIRCRAFT SALE TO GERMANY FOR ESTIMATED COST OF $1.4 BILLION; 08/03/2018 – LOCKHEED MARTIN – CO TO DEVELOP & PRODUCE UNARMED RE-ENTRY VEHICLES FOR INTEGRATION INTO TARGET MISSILES THROUGH 2022; 30/05/2018 – LOCKHEED EXPECTS TO DELIVER 650 OF ITS F-35 FIGHTERS BY 2020; 16/03/2018 – Lockheed Martin: U.S. Army Pact for Sustainment of Training Aids; 24/04/2018 – Lockheed Closes Below 50-Day Moving Average: Technicals; 24/04/2018 – LOCKHEED MARTIN CORP SEES 2018 NET SALES $50,350 MLN $51,850 MLN; 26/04/2018 – MATTIS: WORKING WITH LOCKHEED TO CUT PURCHASE, SUPPORT COSTS

Among 18 analysts covering EXACT Sciences (NASDAQ:EXAS), 11 have Buy rating, 1 Sell and 6 Hold. Therefore 61% are positive. EXACT Sciences had 78 analyst reports since July 24, 2015 according to SRatingsIntel. Cowen & Co maintained Exact Sciences Corporation (NASDAQ:EXAS) on Friday, August 4 with “Buy” rating. As per Wednesday, June 6, the company rating was maintained by Canaccord Genuity. Benchmark maintained it with “Buy” rating and $65.0 target in Wednesday, January 17 report. The stock has “Buy” rating by Roth Capital on Wednesday, July 26. As per Friday, October 30, the company rating was maintained by TH Capital. Roth Capital maintained Exact Sciences Corporation (NASDAQ:EXAS) on Friday, October 30 with “Buy” rating. On Tuesday, April 3 the stock rating was upgraded by BTIG Research to “Buy”. The stock has “Neutral” rating by Mizuho on Wednesday, May 4. The firm earned “Hold” rating on Friday, February 23 by Stephens. On Tuesday, October 31 the stock rating was maintained by Leerink Swann with “Outperform”.

Investors sentiment increased to 1.15 in Q1 2018. Its up 0.27, from 0.88 in 2017Q4. It improved, as 43 investors sold EXAS shares while 80 reduced holdings. 54 funds opened positions while 88 raised stakes. 101.92 million shares or 10.20% more from 92.48 million shares in 2017Q4 were reported. Moreover, Mgmt Co has 0.01% invested in Exact Sciences Corporation (NASDAQ:EXAS). Citigroup Inc invested in 13,931 shares. Susquehanna Gru Ltd Liability Partnership has 44,195 shares for 0% of their portfolio. Crow Point Limited Liability Com owns 2,410 shares. Kistler reported 0% in Exact Sciences Corporation (NASDAQ:EXAS). Horseman Capital Mgmt Ltd holds 0.22% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS) for 27,000 shares. California State Teachers Retirement Sys has invested 0.02% in Exact Sciences Corporation (NASDAQ:EXAS). Primecap Co Ca holds 3.58 million shares. Qs Invsts Lc owns 80,127 shares. Chicago Equity Prtn Ltd Liability Com has invested 0.05% in Exact Sciences Corporation (NASDAQ:EXAS). Moreover, Artisan Prns LP has 0.12% invested in Exact Sciences Corporation (NASDAQ:EXAS). Teacher Retirement Systems Of Texas owns 26,562 shares for 0.01% of their portfolio. The Missouri-based Parkside National Bank & Trust Trust has invested 0% in Exact Sciences Corporation (NASDAQ:EXAS). M&T Retail Bank Corporation has invested 0% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS). Nicholas Inv LP reported 104,723 shares.

Eventide Asset Management Llc decreased Prothena Corp Plc (NASDAQ:PRTA) stake by 83,000 shares to 37,000 valued at $1.36M in 2018Q1. It also reduced Eiger Biopharmaceuticals Inc stake by 62,000 shares and now owns 63,000 shares. Loxo Oncology Inc (NASDAQ:LOXO) was reduced too.

More notable recent Exact Sciences Corporation (NASDAQ:EXAS) news were published by: Seekingalpha.com which released: “Exact Sciences advancing biomarker panel for liver cancer” on June 05, 2018, also Seekingalpha.com with their article: “Exact Sciences upsizes and prices of 1.0% convertible senior notes due 2025” published on June 08, 2018, Fool.com published: “20 Million More Potential Customers for Cologuard: Time to Buy Exact Sciences Stock?” on June 04, 2018. More interesting news about Exact Sciences Corporation (NASDAQ:EXAS) were released by: Streetinsider.com and their article: “Exact Sciences (EXAS) PT Raised to Street High $75 at Canaccord, ‘Strong execution in a robust bull market'” published on June 15, 2018 as well as Fool.com‘s news article titled: “Where Will Exact Sciences Corporation Be in 5 Years?” with publication date: May 29, 2018.

Since January 2, 2018, it had 0 insider purchases, and 21 sales for $25.11 million activity. 125,402 shares valued at $6.62M were sold by Conroy Kevin T on Friday, January 12. Another trade for 2,982 shares valued at $126,252 was sold by Elliott Jeffrey Thomas. Doyle James Edward sold $126,925 worth of stock or 3,098 shares. 8,448 Exact Sciences Corporation (NASDAQ:EXAS) shares with value of $335,630 were sold by Carey Thomas D.. 4,420 shares valued at $187,134 were sold by COWARD D SCOTT on Friday, February 23. LIDGARD GRAHAM PETER sold 14,550 shares worth $756,271. ARORA MANEESH also sold $276,367 worth of Exact Sciences Corporation (NASDAQ:EXAS) on Friday, March 9.

Since January 29, 2018, it had 0 insider buys, and 2 selling transactions for $9.28 million activity. HEWSON MARILLYN A also sold $6.59M worth of Lockheed Martin Corporation (NYSE:LMT) on Monday, January 29. $2.69 million worth of Lockheed Martin Corporation (NYSE:LMT) shares were sold by Ambrose Richard F.

More notable recent Lockheed Martin Corporation (NYSE:LMT) news were published by: Seekingalpha.com which released: “Buy Lockheed Martin On Weakness – Cramer’s Lightning Round (6/14/18)” on June 15, 2018, also Seekingalpha.com with their article: “F-35 used in combat for first time” published on May 22, 2018, Seekingalpha.com published: “Lockheed Martin: The Time To Buy Is Now” on May 21, 2018. More interesting news about Lockheed Martin Corporation (NYSE:LMT) were released by: Bizjournals.com and their article: “Exclusive: Local tech firm grabs piece of $3.5B Lockheed Martin contract, to create 65+ jobs” published on June 14, 2018 as well as Fool.com‘s news article titled: “NASA’s Space Launch System: Rocketing Towards Cancellation?” with publication date: June 16, 2018.

Among 23 analysts covering Lockheed Martin Corporation (NYSE:LMT), 13 have Buy rating, 0 Sell and 10 Hold. Therefore 57% are positive. Lockheed Martin Corporation has $410.0 highest and $204 lowest target. $333.33’s average target is 7.48% above currents $310.14 stock price. Lockheed Martin Corporation had 86 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Wednesday, July 19 with “Hold”. Buckingham Research maintained Lockheed Martin Corporation (NYSE:LMT) on Thursday, October 5 with “Buy” rating. On Wednesday, January 6 the stock rating was upgraded by RBC Capital Markets to “Outperform”. Barclays Capital maintained the stock with “Underweight” rating in Tuesday, February 16 report. The stock has “Buy” rating by Sterne Agee CRT on Thursday, August 20. As per Friday, June 9, the company rating was maintained by RBC Capital Markets. On Tuesday, January 30 the stock rating was maintained by Bernstein with “Hold”. The firm earned “Buy” rating on Thursday, March 17 by Berenberg. JP Morgan reinitiated the shares of LMT in report on Monday, October 12 with “Neutral” rating. The stock has “Hold” rating by Credit Suisse on Wednesday, July 19.

Lockheed Martin Corporation (NYSE:LMT) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>